Browse by category

Results from the ESSENCE Phase III clinical trial show treating patients with semaglutide can halt and even reverse liver disease, the...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Patients with obesity and fatty liver-related cirrhosis who had bariatric surgery significantly lowered their future risk of developing...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

An increase in the numbers of activated B cells in the gastrointestinal tract drive inflammatory fatty liver disease (NASH, non-alcoholic...

Two new secondary analyses of the STEP TEENS trial presented at this year's European Congress on Obesity have reported that almost half...

Patients with obesity and advanced fatty liver disease who had bariatric surgery significantly lowered their future risk of liver disease...

A longitudinal national study led by Virginia Commonwealth University researcher, Dr Arun Sanyal, revealed that people with advanced...

Non-alcoholic fatty liver disease (NAFLD) has been reported in approximately 70-90% of patients with morbid obesity undergoing metabolic...